Search research articles
Contact Us
Filters
Showing results (281-290 of 490) with videos related to
Page
of 49
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach
Balwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial
Lisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
Anti-Cancer Drugs
|
June 5, 2003
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study
Claudia Pföhler, Ian A Cree, Selma Ugurel, et al.
Stem Cell Research
|
May 23, 2015
Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neurons
Sandra Horschitz, Friederike Matthäus, Anja Groß, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2021
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
Anne Zaremba, Manuel Philip, Jessica C Hassel, et al.
Pigment Cell & Melanoma Research
|
April 24, 2016
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells
Kasia Weina, Huizi Wu, Nathalie Knappe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 1, 2011
Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma
Daniel Hausmann, Susanne Jochum, Jochen Utikal, et al.
Blood
|
December 17, 2005
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway
Julia Kzhyshkowska, Srinivas Mamidi, Alexei Gratchev, et al.
Cellular Immunology
|
December 31, 2020
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study
Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 490) with videos related to
Sort By:
Page
of 49
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach
Balwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial
Lisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
Anti-Cancer Drugs
|
June 5, 2003
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study
Claudia Pföhler, Ian A Cree, Selma Ugurel, et al.
Stem Cell Research
|
May 23, 2015
Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neurons
Sandra Horschitz, Friederike Matthäus, Anja Groß, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2021
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
Anne Zaremba, Manuel Philip, Jessica C Hassel, et al.
Pigment Cell & Melanoma Research
|
April 24, 2016
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells
Kasia Weina, Huizi Wu, Nathalie Knappe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 1, 2011
Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma
Daniel Hausmann, Susanne Jochum, Jochen Utikal, et al.
Blood
|
December 17, 2005
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway
Julia Kzhyshkowska, Srinivas Mamidi, Alexei Gratchev, et al.
Cellular Immunology
|
December 31, 2020
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study
Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.
Page
of 49